Towards Healthcare
Europe Clinical Trials Market to Lead USD 21.73 Bn by 2034

Europe Clinical Trials Market Boosted by AI and Regulations 2025

Market insights predict the Europe clinical trials industry will increase from USD 13.6 billion in 2024 to USD 21.73 billion by 2034, achieving a CAGR of 4.80%. The Europe clinical trials market is expanding due to stringent regulations as well as growing innovations.

  • Last Updated: 13 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The Europe clinical trials market is worth USD 14.25 billion in 2025, and by 2034, it is forecasted to hit USD 21.73 billion, registering a CAGR of 4.80% over the decade.

The Europe clinical trials market is significantly growing due to the presence of a unified regulatory framework.

The Europe clinical trials market includes 3 segments such as by phase, by study design, and by indication.

Some key players include Novo Nordisk, Syneos Health, AstraZeneca, and Novartis.

The area of interest for Europe clinical trials includes the development of lung cancer vaccines, personalized vaccines, HIV prevention solutions, and other treatment options.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.